Biotech Industry Complains of Patent Bottleneck in Taiwan
Taiwanese biotech patents are bottlenecked at the Intellectual Property Office (IPO) due to the lack of examiners to cope with the workload, experts at an industry conference complained Thursday, according to...To view the full article, register now.
Already a subscriber? Click here to view full article